Skip to content

Effect of transcutaneous auricular vagus nerve stimulation on perioperative negative emotions in patients undergoing breast cancer surgery: a randomized controlled trial

Effect of transcutaneous auricular vagus nerve stimulation on perioperative negative emotions in patients undergoing breast cancer surgery: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119901
Enrollment
Unknown
Registered
2026-03-05
Start date
2026-03-09
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Treatment Group:Transcutaneous auricular vagus nerve stimulation (taVNS)

Sponsors

The First Medical Center of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years. 2. Scheduled to undergo elective breast cancer resection surgery. 3. American Society of Anesthesiologists (ASA) physical status classification of I-III. 4. The patient or their authorized legal representative voluntarily signs the informed consent form, agrees to participate in this study, and cooperates to complete the collection of all observation indicators.

Exclusion criteria

Exclusion criteria: 1. Presence of other interfering factors for cognitive assessment, with a preoperative Mini-Mental State Examination (MMSE) score < 24; severe language communication barriers, hearing impairment, or visual impairment that cannot be compensated for with auxiliary means to cooperate with the assessment. 2. Previous diagnosis of cognitive or psychiatric disorders such as dementia, Parkinson's disease, schizophrenia, bipolar disorder, or major depressive disorder; long-term use of antipsychotics, anxiolytics/antidepressants, sedative-hypnotics, or other medications affecting mental status that cannot be discontinued or adjusted. 3. Presence of skin lesions, infections, ulcers, keloids, severe dermatitis, or congenital ear deformities in both ears that prevent effective fixation of taVNS electrodes; history of ear surgery or ear nerve injury; allergy to taVNS electrode materials or conductive gel. 4. Comorbid severe arrhythmia; implanted electronic devices such as cardiac pacemakers, implantable cardioverter defibrillators, or deep brain stimulators. 5. Participation in other interventional clinical studies within the past 3 months; other circumstances deemed by the investigator as unsuitable for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
Incidence of depressive symptoms;

Secondary

MeasureTime frame
incidence of anxiety symptoms;postoperative nausea and vomiting;postoperative pain score;postoperative sleep quality;time to first postoperative flatus and defecation;

Countries

China

Contacts

Public ContactWeidong Mi

The First Medical Center of Chinese PLA General Hospital

caichen301@sina.com+86 133 8108 2966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026